ASX Announcement Annual General Meeting 2026 Date Melbourne, Australia; 15 September 2026: Starpharma (ASX: SPL, US OTC: SPHRY), an innovative biotechnology company advancing dendrimer technology from the lab to the patient, today announces, in accordance with ASX Listing Rule 3.13.1, that its 2026...